COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations
Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.
A ‘disquieting plateau’: Healthcare costs are up, but survival among heart patients stays the same
The cardiovascular mortality rate in the United States decreased dramatically from 2000 to 2011. Since then, however, it has remained relatively unchanged.
Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine
The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.
PHOTO GALLERY: What does acute COVID-19 and long COVID look like on medical imaging?
This image gallery shows what the various clinical presentations associated with the COVID-19 and long COVID that have been documented during and after coronavirus pandemic.
Scientists discover link between Alzheimer's and long COVID on MRI scans
Imaging findings pertaining to the size of and blood flowing to the choroid plexus may be a common denominator between the two conditions.

JPMorgan moves annual healthcare conference online following omicron concerns

Biotech giants Moderna and Amgen both recently dropped out of the in-person meeting, which was set to take place next month in San Francisco.

Pfizer says its pill remains 89% effective against COVID-19 in final study results

The health giant also noted that the antiviral worked in lab studies against the omicron variant.

Assessing blood samples with new device pinpoints early warning signs for COVID-19 patients

The researchers found an unusually high amount of platelet aggregation in patient samples, a known indicator of microvascular thrombosis.

Senators to question cardiologist Robert Califf, Biden’s nominee to lead FDA, on industry ties and COVID-19 response

Could Califf's connections to the pharmaceutical industry keep him from being approved as the next FDA commissioner?

FDA expands Pfizer booster shots to 16- and 17-year-olds

The emergency authorization paves the way for millions of younger adults to get a third dose of the vaccine.

Breathlessness among patients with long COVID may be a sign of heart damage

Researchers presented their findings at EuroEcho 2021.

Cardiologist back at work after testing positive for Omicron COVID-19 variant

The cardiologist says he stayed away from his wife and children for 10 days to limit any risk of spreading the virus.

Autopsies suggest we still have a lot to learn about COVID-19's impact on the heart

Researchers focused on patients who died during the early stages of the pandemic.

COVID-19

ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations

A ‘disquieting plateau’: Healthcare costs are up, but survival among heart patients stays the same

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

PHOTO GALLERY: What does acute COVID-19 and long COVID look like on medical imaging?

Scientists discover link between Alzheimer's and long COVID on MRI scans